Advanced technology and a design that puts well-being first come together in the new Stanford Hospital
How the new $2 billion Stanford Hospital is poised to serve the community for 100 years
Works of art and views of nature promote healing at the new hospital
How Stanford physicians and researchers prepare patients to thrive after surgery
Building a culture of teamwork in emergency care
Guided by lasers, fluorescence and real-time imaging, surgeons develop new ways to enhance precision
Behind the scenes in a hospital kitchen
Letter from the Dean
Expanding on unparalleled patient care
The best possible resources with the best possible environment for precision health
Using in-game win probability techniques to predict the course of disease
When nerve cells’ power packs go wrong
English, math and even science experiments help school-aged patients keep up
Understanding the neurology of snoozing zebrafish could solve the mysteries of human sleep
The future is here
A quick look at the latest development from Stanford Medicine
The experimental drug filgotinib blocks a set of enzymes that cause inflammation in rheumatoid arthritis patients who haven’t benefitted from other treatments, a study shows.
Anew drug combination for chronic lymphocytic leukemia could herald a new standard of treatment, researchers find.
Inflammation from a simple infection can awaken a silent genetic defect in rats that carry it, resulting in a deadly form of pulmonary hypertension, a study shows.
Brain scans of a group of adolescents in California’s Salinas Valley show a direct link between pesticides they were exposed to in utero and certain brain functions.
Stimulating cells that jump in to protect healthy tissues in MS patients when their immune systems attack could lead to new drug therapies, researcher says.
Researchers ID cells that transform into tissue that caps off plaque in atherosclerosis. They also believe they’ve found the gene responsible for the transformation.
: Pivotal response therapy that taps into the interests of children with autism, is better than existing therapies at motivating them to talk, a new study shows.